Bitwise Solana Staking ETF
BSOLNYSEFinancials · Commodity Contracts Brokers & Dealers · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | |
|---|---|
| Revenue | — |
| Operating income | — |
| Net income | −$206.5M |
| Total assets | $641.3M |
| Total liabilities | $0 |
| Equity | — |
| EPS (diluted) | — |
| Shares out. | 39.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- —
- Return on assets
- −32.2%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 0.0%
- Debt / equity
- —
- Book value / share
- —
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- 44.2%high accruals
- Piotroski F-Score
- 0/3weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 warning● 1 good- Negative operating cash flow
- High accruals — earnings-quality risk
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 408,047 | 1.0 | -32.9% |
| Apr 30, 2026 | 608,468 | 1.0 | -42.9% |
| Apr 15, 2026 | 1.1M | 1.0 | +208.6% |
| Mar 31, 2026 | 345,443 | 1.0 | -51.6% |
| Mar 13, 2026 | 714,534 | 1.0 | +81.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 10-QMay 6, 2026
- 424IMar 27, 2026
- 10-KMar 20, 2026
- 10-QNov 10, 2025
- 424B3PROSPECTUSOct 28, 2025
- POS EXPOST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1Oct 28, 2025
- CERTNYSE ARCA CERTIFICATIONOct 27, 2025
- 8-A12B/AAMENDMENT NO. 1 TO FORM 8-A12BOct 23, 2025
- S-1/AAMENDMENT NO. 5 TO FORM S-1Oct 8, 2025
- 8-A12BFOR REGISTRATION OF CERTAIN CLASSESSep 26, 2025
- S-1/AAMENDMENT NO. 4 TO FORM S-1Sep 26, 2025
- S-1/AAMENDMENT NO. 3 TO FORM S-1Aug 29, 2025
- S-1/AAMENDMENT NO. 2 TO FORM S-1Jul 31, 2025
- S-1/AAMENDMENT NO. 1 TO FORM S-1Jun 13, 2025
- S-1REGISTRATION STATEMENTNov 21, 2024